microRNA 3650 (miR-3650)

microRNA 3650 (miR-3650, MIR3650, hsa-miR-3650) is a member of the microRNA (miRNA) family, which are small, single-stranded, non-coding RNA molecules roughly 21–23 nucleotides in length[1]. miRNAs function primarily by base-pairing with complementary sequences within messenger RNA (mRNA) molecules, leading to gene silencing through cleavage of the mRNA, degradation, or inhibition of translation[1][2][3]. These molecules are processed from a hairpin precursor by the enzymes Drosha and Dicer[3][4]. While miRNAs overall have a broad role in regulating gene expression, cell differentiation, and maintenance of cellular homeostasis, as well as being implicated in buffering gene networks against environmental or developmental fluctuations[2][3], there is currently very limited published functional or disease-association data specific to miR-3650 in the scientific literature and curated databases. miRNAs as a class can serve as disease biomarkers, but miR-3650 is not a widely established or clinically used biomarker at this time[1]. No known drugs or clinical agents are reported to directly interact with or target miR-3650; mechanisms of clinical intervention for specific miRNAs generally involve antisense oligonucleotides or gene therapy strategies, but there is no evidence these are in use for miR-3650[1][2][3]. microRNA 3650 is a non-coding RNA involved in gene regulation at the post-transcriptional level as part of the microRNA family, but currently, there is no strong evidence it is a direct therapeutic target or clinically validated biomarker. It is not associated with receptors, enzymes, or other common druggable target classes, and limited research is available on its specific biological or disease roles.

Other names

MIR3650hsa-mir-3650hsa-miR-3650